secwatch.observer — SEC 8-K summary
======================================

Issuer:     Oncology Institute, Inc. (TOI)
CIK:        0001799191
Form:       8-K
Filed at:   2025-04-11T23:59:59+00:00
Accession:  0001079973-25-000610
Event type: regulatory
Sentiment:  positive
Materiality: 0.55
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Oncology Institute regains Nasdaq minimum bid price compliance
--------------------------------------------------------------

- Received Nasdaq notice on Apr 9, 2025 that closing bid was $1.00+ for 12 consecutive days through Apr 8.
- Had been non-compliant since June 2024; granted extension to June 16, 2025 before cure.
- Compliance removes immediate delisting risk for common (TOI) and warrants (TOIIW).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1799191/000107997325000610/0001079973-25-000610-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1799191/000107997325000610/toi_8k.htm
  HTML page:      https://secwatch.observer/filing/0001079973-25-000610

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer